ICN PHARMS., INC. v. BRISTOL-MYERS CO.


245 A.D.2d 182 (1997)

666 N.Y.S.2d 185

ICN Pharmaceuticals, Inc., as Successor in Interest to SPI Pharmaceuticals, Inc., Respondent, v. Bristol-Myers Company, Appellant

Appellate Division of the Supreme Court of the State of New York, First Department.

December 18, 1997


The issue of whether plaintiff's predecessor was unable to continue to market the product manufactured by defendant due to defendant's material breach of the Supply Agreement, and was therefore entitled to return of the advance fee as provided in the related License Agreement, was not necessary to the determinations in the prior arbitration proceeding that defendant had materially breached the Supply Agreement but that plaintiff's predecessor was not entitled to damages thereunder...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases